查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2049370

栓塞預防裝置市場分析：按產品、應用、手術、材料、使用方法、最終用戶和地區分類（2026-2034 年）

Embolic Protection Devices Market Report by Product, Application, Procedure, Material, Usage, End-User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球栓塞預防器材市場規模達13.226億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到23.079億美元，2026年至2034年的複合年成長率為6.19%。推動市場成長的主要因素包括：人們對微創手術的認知不斷提高、心血管疾病盛行率上升以及醫療技術的顯著進步。

栓塞預防裝置是一種專門設計的醫療器械，旨在防止微創手術（尤其是介入心臟病學）過程中碎片、血栓或其他潛在有害顆粒的移動。這些裝置起到過濾器或屏障的作用，捕獲並控制可能隨血液循環而擴散並導致中風或器官損傷等併發症的栓子。透過保護重要動脈並降低栓塞風險，這些裝置提高了血管成形術、支架置入術和動脈粥狀硬化斑塊切除術等手術的安全性和成功率。因此，栓塞預防裝置在醫療產業中已廣泛應用，因為它們在最大限度地減少術後栓塞併發症的可能性和維護患者健康方面發揮著至關重要的作用。

動脈粥狀硬化和冠狀動脈疾病等心血管疾病的日益普遍，推動了預測期內抗栓塞器械市場的成長，因為這增加了對抗栓塞器械的需求，以降低介入治療過程中發生栓塞的風險。此外，微創技術在各醫療專科領域的日益普及也促進了對抗栓塞器材的需求。這些器械對於確保患者在血管成形術、支架置入術和經導管主動脈瓣置換術(TAVR) 等複雜手術中的安全性至關重要。此外，眾多能夠提升器械性能和改善病患預後的技術進步，例如改進的濾網設計和材料創新，也在推動市場成長。而且，人們越來越重視減少術後併發症和縮短住院時間，這加速了有助於預防栓塞事件的抗栓塞器械的應用，從而促進了市場成長。

栓塞預防器材的市場趨勢與促進因素：

心血管疾病盛行率增加

心血管疾病（例如動脈粥狀硬化和冠狀動脈疾病）的激增是抗栓塞器械市場的主要驅動力。全球人口老化和生活方式因素導致全球健康問題日益嚴重，進而促使血管成形術和支架置入術等治療方法的使用率不斷上升。抗栓塞器械在降低栓塞風險方面發揮著至關重要的作用，栓塞是一種可能導致中風等嚴重後果的併發症。這些器械透過捕捉和控制手術過程中的碎片，顯著提高了病患安全性和整體治療效果。對抗栓塞器材需求的成長源自於醫療專業人員為應對日益加重的全球心血管疾病負擔並最大限度地降低相關手術風險所做的努力。

微創手術的趨勢日益成長

微創技術在各醫療專科領域的日益普及，刺激了對栓塞預防裝置的需求。這些裝置對於確保經導管治療等栓塞風險較高的手術中的病人安全至關重要。隨著患者和醫護人員越來越傾向於選擇能夠帶來更快康復和更短住院時間的微創方法，有效預防栓塞的需求變得特別迫切。這些裝置適用於多種微創手術，凸顯了它們在現代醫療保健中的重要性，以及它們在最佳化患者預後和提高手術成功率方面發揮的關鍵作用。

科技的快速發展

器械技術的持續創新，包括精密的過濾器設計、先進的材料和改進的部署機制，是抗栓塞器械市場發展的關鍵驅動力。醫療專業人員需要能夠在介入治療過程中提供卓越性能和安全性的工具。抗栓塞器械的演進有效地滿足了這些需求，從而實現了更有效率的碎片捕獲、更有效率的手術操作和更佳的患者預後。隨著能夠提升手術效率和患者健康的創新解決方案在醫療領域日益重要，對先進抗栓塞器材的追求正在推動市場發展，並為醫療專業人員及其患者帶來顯著的益處。

目錄

第1章：序言

第2章：分析的範圍與方法

  • 分析目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 分析方法

第3章執行摘要

第4章：引言

第5章：全球栓塞預防裝置市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 遠端濾網裝置
  • 遠端閉塞裝置
  • 近中咬合裝置

第7章 市場區隔：依應用領域分類

  • 冠狀動脈治療
  • 頸動脈治療
  • 其他

第8章 市場區隔：依治療方式分類

  • 經皮冠狀動脈介入治療
  • 頸動脈狹窄
  • 採用大隱靜脈移植進行治療
  • 主動脈瓣狹窄（經導管主動脈瓣置換術）
  • 其他

第9章 市場區隔：依材料分類

  • 鎳鈦諾
  • 聚氨酯

第10章 市場區隔：依用途分類

  • 免洗設備
  • 可重複使用設備

第11章 市場區隔：依最終用戶分類

  • 醫院和診所
  • 門診手術中心
  • 其他

第12章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第13章 SWOT 分析

第14章：價值鏈分析

第15章：波特五力分析

第16章 價格指標

第17章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abbott Laboratories
    • Allium Medical Solutions Ltd.
    • Boston Scientific Corporation
    • Cardinal Health Inc.
    • Contego Medical LLC
    • Innovative Cardiovascular Solutions LLC
    • Edwards Lifesciences Corporation
    • Medtronic Inc.
    • Silk Road Medical Inc.
Product Code: SR112026A2202

The global embolic protection devices market size reached USD 1,322.6 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 2,307.9 Million by 2034, exhibiting a growth rate (CAGR) of 6.19% during 2026-2034. The increasing awareness of minimally invasive procedures, rising prevalence of cardiovascular diseases, and numerous advancements in medical technology are some of the major factors propelling the market.

Embolic protection devices are specialized medical tools designed to prevent the migration of debris, blood clots, or other potentially harmful particles during minimally invasive procedures, particularly in cardiovascular interventions. These devices act as filters or barriers, capturing and containing emboli that could otherwise travel through the bloodstream and cause complications such as stroke or organ damage. By safeguarding vital arteries and reducing the risk of embolization, these devices improve the safety and success rates of procedures like angioplasty, stent placement, and atherectomy. As a result, embolic protection devices find extensive applications across the healthcare industry as they play a crucial role in preserving patient well-being by minimizing the potential for post-procedural complications arising from embolism.

The rising demand for embolic protection devices to mitigate the risks of embolization during interventions due to the increasing prevalence of cardiovascular diseases such as atherosclerosis and coronary artery disease will stimulate the growth of the embolic protection devices market during the forecast period. Moreover, the increasing adoption of minimally invasive techniques across various medical specialties has augmented the demand for embolic protection devices. These devices are integral to preserving patient safety during complex procedures like angioplasty, stenting, and transcatheter aortic valve replacement. Apart from this, numerous technological advancements, including improved filter designs and material innovation, that enhance performance and patient outcomes, are propelling the market growth. Furthermore, the heightened emphasis on reducing post-procedural complications and hospital stays has accelerated the adoption of embolic protection devices as it assists in preventing embolic events, thereby contributing to the market growth.

EMBOLIC PROTECTION DEVICES MARKET TRENDS/DRIVERS:

Rise in prevalence of cardiovascular diseases

The surge in cardiovascular diseases like atherosclerosis and coronary artery diseases acts as a primary driver in the embolic protection device market. With an aging global population and lifestyle factors contributing to health concerns worldwide, interventions such as angioplasty and stent placement are becoming more prevalent. Embolic protection devices play a critical role in mitigating the risks of embolization, a potential complication that can lead to severe consequences like stroke. By capturing and containing debris during these procedures, these devices significantly improve patient safety and overall procedural outcomes. The growing demand for embolic protection devices stems from healthcare professionals' commitment to addressing the mounting burden of cardiovascular diseases globally and minimizing the associated procedural risks.

Growing inclination toward minimally invasive procedures

The increasing adoption of minimally invasive techniques across diverse medical specialties stimulates the demand for embolic protection devices. These devices are essential for ensuring patient safety during procedures like transcatheter interventions, where the risk of embolization is significant. As patients and healthcare providers gravitate toward less invasive approaches, offering quicker recovery and shorter hospital stays, the need for effective embolic protection becomes paramount. The adaptability of these devices to various minimally invasive (MI) procedures underscores their significance in modern medical practice, where they play a crucial role in optimizing patient outcomes and procedural success.

Rapid technological advancements

Continuous innovations in device technology, including refined filter designs, advanced materials, and improved deployment mechanisms, are pivotal drivers of the embolic protection device market. Healthcare professionals seek tools that deliver enhanced performance and safety during interventions. The evolution of embolic protection devices effectively addresses these demands, providing better debris capture, streamlined procedures, and improved patient outcomes. As the medical field increasingly prioritizes novel solutions that enhance both procedural efficacy and patient well-being, the quest for sophisticated embolic protection devices propel the market forward, offering significant benefits to medical practitioners and the patients they serve.

EMBOLIC PROTECTION DEVICES INDUSTRY SEGMENTATION:

Breakup by Product:

  • Distal Filter Devices
  • Distal Occlusion Devices
  • Proximal Occlusion Devices

Distal filter devices dominate the market

Distal filter devices have emerged as a driving force within the embolic protection devices market due to their pivotal role in minimizing embolic events during interventional procedures. These devices employ finely engineered filters positioned downstream to capture and contain debris released during procedures such as transcatheter interventions and angioplasty. By effectively intercepting emboli and preventing their migration to vital vessels, distal filter devices significantly mitigate the risk of complications, notably strokes.

Moreover, the growing recognition of their efficacy in preserving cerebral and peripheral circulation has spurred their adoption among healthcare professionals, leading to an increased demand for such devices. As a result, distal filter devices have enhanced patient outcomes and safety while supporting the overall growth trajectory of the embolic protection devices industry, underscoring their significance in modern medical interventions.

Breakup by Application:

  • Coronary Artery Treatment
  • Carotid Artery Treatment
  • Others

Coronary artery treatment holds the largest share in the market

Coronary artery treatment devices exert a substantial influence on the embolic protection devices market by addressing the inherent risk of embolic events in coronary interventions. These devices encompass a wide range of advanced technologies, including stents, angioplasty balloons, and atherectomy systems, all of which hold the potential to dislodge embolic debris during procedures. To counter this risk, embolic protection devices are integrated to capture and contain such debris, preventing its migration and minimizing adverse outcomes.

Furthermore, the growing demand for effective embolic protection strategies in coronary interventions has accelerated the adoption of dedicated embolic protection devices, as they strengthen the safety profile of coronary procedures, reducing the likelihood of complications such as myocardial infarctions and strokes. This symbiotic relationship between coronary artery treatment devices and embolic protection devices underscores their collective role in enhancing patient care and shaping the evolving landscape of cardiovascular interventions.

Breakup by Procedure:

  • Percutaneous Coronary Intervention
  • Carotid Artery Stenosis
  • Saphenous Vein Graft Intervention
  • Aortic Valve Stenosis (Transcatheter Aortic Valve Replacement)
  • Others

Percutaneous coronary intervention represents the most widely used procedure

Percutaneous coronary intervention (PCI) significantly influences the embolic protection devices market due to its widespread use in treating coronary artery disease. PCI procedures involve the deployment of stents and other devices to open narrowed or blocked coronary arteries. However, these interventions carry the risk of embolic debris dislodgement, potentially leading to adverse events.

Furthermore, embolic protection devices play a crucial role in mitigating this risk by capturing and containing such debris, thereby reducing the chance of downstream embolization and associated complications. As PCI procedures continue to be a cornerstone of coronary artery disease management, the demand for effective embolic protection strategies has increased, fueling the growth of the market for embolic protection devices. This interdependence underscores the vital role of embolic protection devices in fortifying the safety and efficacy of percutaneous coronary interventions.

Breakup by Material:

  • Nitinol
  • Polyurethane

Nitinol represents the most popular material

Nitinol, a shape memory alloy with remarkable flexibility and thermal properties, plays a crucial role in driving the embolic protection devices market. This material's unique attributes make it an ideal choice for constructing filters and frames in embolic protection devices. Nitinol's ability to undergo controlled deformation and return to its original shape when exposed to heat enables the creation of intricate yet resilient designs that can navigate tortuous vessels while maintaining structural integrity. This exceptional combination of properties enhances the performance of embolic protection devices by ensuring optimal vessel coverage and debris capture. As healthcare professionals seek devices that offer both efficacy and adaptability during interventions, Nitinol-based embolic protection devices stand out as an essential driver in shaping the market's growth, ultimately contributing to improved patient outcomes in various vascular procedures.

Breakup by Usage:

  • Disposable Devices
  • Re-Usable Devices

Disposable devices account for the majority of the market share

Disposable devices aids in addressing critical concerns related to infection control, convenience, and cost-effectiveness. These disposable devices, designed for single-use applications, eliminate the need for reprocessing and sterilization, thereby minimizing the risk of cross-contamination and enhancing procedural efficiency. Moreover, they offer healthcare providers a hassle-free solution that reduces the burden of equipment maintenance.

Furthermore, the escalating demand for infection prevention measures and streamlined workflows has fueled the adoption of disposable embolic protection devices in various interventional procedures, spanning from endovascular interventions to transcatheter techniques. As medical settings prioritize patient safety and operational ease, the prominence of disposable embolic protection devices continues to escalate, substantiating their pivotal role in catalyzing the growth and evolution of the embolic protection devices market.

Breakup by End-User:

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others

Hospitals and clinics represent the leading end user segment

As healthcare facilities, such as hospitals and clinics, continually strive to enhance patient outcomes and safety, the demand for effective embolic protection strategies has grown.

Moreover, hospitals and clinics actively seek advanced embolic protection devices to integrate into various interventional procedures, such as angioplasty, stent placement, and transcatheter interventions. The imperative to minimize the risk of embolic events, coupled with the need for streamlined procedural workflows, accelerates the adoption of these devices. Furthermore, as healthcare providers prioritize evidence-based practices, the utilization of embolic protection devices aligns with best practices for reducing complications and improving patient care, thus solidifying hospitals and clinics as key drivers in shaping the embolic protection devices market's expansion.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest share in the market due to its robust healthcare infrastructure, technological advancements, and high prevalence of cardiovascular diseases. The region's well-established healthcare facilities, coupled with a strong emphasis on patient safety and outcomes, catalyze the demand for effective embolic protection strategies. Favorable reimbursement policies and a propensity for adopting innovative medical technologies further stimulate the adoption of embolic protection devices in diverse cardiovascular interventions.

Additionally, the presence of various key players in the region and ongoing research initiatives contribute to the continuous evolution of embolic protection technologies. With its combination of clinical need, economic factors, and technological readiness, North America has emerged as a leading regional market for embolic protection devices.

COMPETITIVE LANDSCAPE:

Key players in the embolic protection devices market have recently introduced noteworthy innovations to address critical challenges. They have unveiled advanced embolic protection devices with improved navigational capabilities, real-time monitoring features, and enhanced thrombus capture efficiency. These innovations aim to provide healthcare professionals with greater precision and insight during complex procedures like transcatheter interventions and carotid artery stenting. Furthermore, the leading players have invested in developing integrated systems that seamlessly integrate with existing procedural workflows, streamlining the process and minimizing procedural time. These advancements reflect the industry's commitment to refining embolic protection strategies and reinforcing patient safety, thereby solidifying their role as frontrunners in shaping the landscape of embolic protection technologies. We also expect the market to witness new entrants, consolidation of product portfolios, and increased collaborations among manufacturers to drive healthy competition within the embolic protection devices domain.

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Abbott Laboratories
  • Allium Medical Solutions Ltd.
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Contego Medical LLC
  • Innovative Cardiovascular Solutions LLC
  • Edwards Lifesciences Corporation
  • Medtronic Inc.
  • Silk Road Medical Inc.

Key Questions Answered in This Report

1. What was the size of the global embolic protection devices market in 2025?

2. What is the expected growth rate of the global embolic protection devices market during 2026-2034?

3. What has been the impact of COVID-19 on the global embolic protection devices market?

4. What are the key factors driving the global embolic protection devices market?

5. What is the breakup of the global embolic protection devices market based on the product?

6. What is the breakup of the global embolic protection devices market based on the application?

7. What is the breakup of the global embolic protection devices market based on the procedure?

8. What is the breakup of the global embolic protection devices market based on the material?

9. What is the breakup of the global embolic protection devices market based on the usage?

10. What is the breakup of the global embolic protection devices market based on the end-user?

11. What are the key regions in the global embolic protection devices market?

12. Who are the key players/companies in the global embolic protection devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Embolic Protection Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Distal Filter Devices
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Distal Occlusion Devices
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Proximal Occlusion Devices
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Coronary Artery Treatment
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Carotid Artery Treatment
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Procedure

  • 8.1 Percutaneous Coronary Intervention
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Carotid Artery Stenosis
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Saphenous Vein Graft Intervention
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Aortic Valve Stenosis (Transcatheter Aortic Valve Replacement)
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Material

  • 9.1 Nitinol
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Polyurethane
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Usage

  • 10.1 Disposable Devices
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Re-Usable Devices
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast

11 Market Breakup by End-User

  • 11.1 Hospitals and Clinics
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Ambulatory Surgical Centers
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Others
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast

12 Market Breakup by Region

  • 12.1 North America
    • 12.1.1 United States
      • 12.1.1.1 Market Trends
      • 12.1.1.2 Market Forecast
    • 12.1.2 Canada
      • 12.1.2.1 Market Trends
      • 12.1.2.2 Market Forecast
  • 12.2 Asia Pacific
    • 12.2.1 China
      • 12.2.1.1 Market Trends
      • 12.2.1.2 Market Forecast
    • 12.2.2 Japan
      • 12.2.2.1 Market Trends
      • 12.2.2.2 Market Forecast
    • 12.2.3 India
      • 12.2.3.1 Market Trends
      • 12.2.3.2 Market Forecast
    • 12.2.4 South Korea
      • 12.2.4.1 Market Trends
      • 12.2.4.2 Market Forecast
    • 12.2.5 Australia
      • 12.2.5.1 Market Trends
      • 12.2.5.2 Market Forecast
    • 12.2.6 Indonesia
      • 12.2.6.1 Market Trends
      • 12.2.6.2 Market Forecast
    • 12.2.7 Others
      • 12.2.7.1 Market Trends
      • 12.2.7.2 Market Forecast
  • 12.3 Europe
    • 12.3.1 Germany
      • 12.3.1.1 Market Trends
      • 12.3.1.2 Market Forecast
    • 12.3.2 France
      • 12.3.2.1 Market Trends
      • 12.3.2.2 Market Forecast
    • 12.3.3 United Kingdom
      • 12.3.3.1 Market Trends
      • 12.3.3.2 Market Forecast
    • 12.3.4 Italy
      • 12.3.4.1 Market Trends
      • 12.3.4.2 Market Forecast
    • 12.3.5 Spain
      • 12.3.5.1 Market Trends
      • 12.3.5.2 Market Forecast
    • 12.3.6 Russia
      • 12.3.6.1 Market Trends
      • 12.3.6.2 Market Forecast
    • 12.3.7 Others
      • 12.3.7.1 Market Trends
      • 12.3.7.2 Market Forecast
  • 12.4 Latin America
    • 12.4.1 Brazil
      • 12.4.1.1 Market Trends
      • 12.4.1.2 Market Forecast
    • 12.4.2 Mexico
      • 12.4.2.1 Market Trends
      • 12.4.2.2 Market Forecast
    • 12.4.3 Others
      • 12.4.3.1 Market Trends
      • 12.4.3.2 Market Forecast
  • 12.5 Middle East and Africa
    • 12.5.1 Market Trends
    • 12.5.2 Market Breakup by Country
    • 12.5.3 Market Forecast

13 SWOT Analysis

  • 13.1 Overview
  • 13.2 Strengths
  • 13.3 Weaknesses
  • 13.4 Opportunities
  • 13.5 Threats

14 Value Chain Analysis

15 Porters Five Forces Analysis

  • 15.1 Overview
  • 15.2 Bargaining Power of Buyers
  • 15.3 Bargaining Power of Suppliers
  • 15.4 Degree of Competition
  • 15.5 Threat of New Entrants
  • 15.6 Threat of Substitutes

16 Price Indicators

17 Competitive Landscape

  • 17.1 Market Structure
  • 17.2 Key Players
  • 17.3 Profiles of Key Players
    • 17.3.1 Abbott Laboratories
      • 17.3.1.1 Company Overview
      • 17.3.1.2 Product Portfolio
      • 17.3.1.3 Financials
      • 17.3.1.4 SWOT Analysis
    • 17.3.2 Allium Medical Solutions Ltd.
      • 17.3.2.1 Company Overview
      • 17.3.2.2 Product Portfolio
      • 17.3.2.3 Financials
    • 17.3.3 Boston Scientific Corporation
      • 17.3.3.1 Company Overview
      • 17.3.3.2 Product Portfolio
      • 17.3.3.3 Financials
      • 17.3.3.4 SWOT Analysis
    • 17.3.4 Cardinal Health Inc.
      • 17.3.4.1 Company Overview
      • 17.3.4.2 Product Portfolio
      • 17.3.4.3 Financials
      • 17.3.4.4 SWOT Analysis
    • 17.3.5 Contego Medical LLC
      • 17.3.5.1 Company Overview
      • 17.3.5.2 Product Portfolio
    • 17.3.6 Innovative Cardiovascular Solutions LLC
      • 17.3.6.1 Company Overview
      • 17.3.6.2 Product Portfolio
    • 17.3.7 Edwards Lifesciences Corporation
      • 17.3.7.1 Company Overview
      • 17.3.7.2 Product Portfolio
      • 17.3.7.3 Financials
      • 17.3.7.4 SWOT Analysis
    • 17.3.8 Medtronic Inc.
      • 17.3.8.1 Company Overview
      • 17.3.8.2 Product Portfolio
      • 17.3.8.3 Financials
      • 17.3.8.4 SWOT Analysis
    • 17.3.9 Silk Road Medical Inc.
      • 17.3.9.1 Company Overview
      • 17.3.9.2 Product Portfolio
      • 17.3.9.3 Financials

List of Figures

  • Figure 1: Global: Embolic Protection Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Embolic Protection Devices Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Embolic Protection Devices Market: Breakup by Product (in %), 2025
  • Figure 4: Global: Embolic Protection Devices Market: Breakup by Application (in %), 2025
  • Figure 5: Global: Embolic Protection Devices Market: Breakup by Procedure (in %), 2025
  • Figure 6: Global: Embolic Protection Devices Market: Breakup by Material (in %), 2025
  • Figure 7: Global: Embolic Protection Devices Market: Breakup by Usage (in %), 2025
  • Figure 8: Global: Embolic Protection Devices Market: Breakup by End-User (in %), 2025
  • Figure 9: Global: Embolic Protection Devices Market: Breakup by Region (in %), 2025
  • Figure 10: Global: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Embolic Protection Devices (Distal Filter Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Embolic Protection Devices (Distal Filter Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Embolic Protection Devices (Distal Occlusion Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Embolic Protection Devices (Distal Occlusion Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Embolic Protection Devices (Proximal Occlusion Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Embolic Protection Devices (Proximal Occlusion Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Embolic Protection Devices (Coronary Artery Treatment) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Embolic Protection Devices (Coronary Artery Treatment) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Embolic Protection Devices (Carotid Artery Treatment) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Embolic Protection Devices (Carotid Artery Treatment) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Embolic Protection Devices (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Embolic Protection Devices (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Embolic Protection Devices (Percutaneous Coronary Intervention) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Embolic Protection Devices (Percutaneous Coronary Intervention) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Embolic Protection Devices (Carotid Artery Stenosis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Embolic Protection Devices (Carotid Artery Stenosis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Embolic Protection Devices (Saphenous Vein Graft Intervention) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Embolic Protection Devices (Saphenous Vein Graft Intervention) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Embolic Protection Devices (Aortic Valve Stenosis- Transcatheter Aortic Valve Replacement) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Embolic Protection Devices (Aortic Valve Stenosis- Transcatheter Aortic Valve Replacement) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Embolic Protection Devices (Other Procedures) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Embolic Protection Devices (Other Procedures) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Embolic Protection Devices (Nitinol) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Embolic Protection Devices (Nitinol) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Embolic Protection Devices (Polyurethane) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Embolic Protection Devices (Polyurethane) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Global: Embolic Protection Devices (Disposable Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Global: Embolic Protection Devices (Disposable Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Global: Embolic Protection Devices (Re-Usable Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Global: Embolic Protection Devices (Re-Usable Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Global: Embolic Protection Devices (Hospitals and Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Global: Embolic Protection Devices (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Global: Embolic Protection Devices (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Global: Embolic Protection Devices (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Global: Embolic Protection Devices (Other End-Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Global: Embolic Protection Devices (Other End-Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: North America: Embolic Protection Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: North America: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: United States: Embolic Protection Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: United States: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Canada: Embolic Protection Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Canada: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Asia Pacific: Embolic Protection Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Asia Pacific: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: China: Embolic Protection Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: China: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Japan: Embolic Protection Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Japan: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: India: Embolic Protection Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: India: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: South Korea: Embolic Protection Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: South Korea: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Australia: Embolic Protection Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Australia: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Indonesia: Embolic Protection Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Indonesia: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Others: Embolic Protection Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Others: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Europe: Embolic Protection Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Europe: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Germany: Embolic Protection Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Germany: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: France: Embolic Protection Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: France: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: United Kingdom: Embolic Protection Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: United Kingdom: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Italy: Embolic Protection Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Italy: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Spain: Embolic Protection Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Spain: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Russia: Embolic Protection Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: Russia: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 83: Others: Embolic Protection Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 84: Others: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 85: Latin America: Embolic Protection Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 86: Latin America: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 87: Brazil: Embolic Protection Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 88: Brazil: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 89: Mexico: Embolic Protection Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 90: Mexico: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 91: Others: Embolic Protection Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 92: Others: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 93: Middle East and Africa: Embolic Protection Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 94: Middle East and Africa: Embolic Protection Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 95: Global: Embolic Protection Devices Industry: SWOT Analysis
  • Figure 96: Global: Embolic Protection Devices Industry: Value Chain Analysis
  • Figure 97: Global: Embolic Protection Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Embolic Protection Devices Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Embolic Protection Devices Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Embolic Protection Devices Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Embolic Protection Devices Market Forecast: Breakup by Procedure (in Million USD), 2026-2034
  • Table 5: Global: Embolic Protection Devices Market Forecast: Breakup by Material (in Million USD), 2026-2034
  • Table 6: Global: Embolic Protection Devices Market Forecast: Breakup by Usage (in Million USD), 2026-2034
  • Table 7: Global: Embolic Protection Devices Market Forecast: Breakup by End-User (in Million USD), 2026-2034
  • Table 8: Global: Embolic Protection Devices Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 9: Global: Embolic Protection Devices Market: Competitive Structure
  • Table 10: Global: Embolic Protection Devices Market: Key Players